-
Founded in:
1999-06-30 -
Country:
China -
Address:
Cross-Strait Science and Technology Industrial Development Park, Chengdu, Sichuan Province -
Tax NO.:
91510115729806121C -
Registered Funds:
28.3957 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| artificial moschus |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 | ||
| Momordica cochinchinensis (shell and oil removed) |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 | ||
| ACONITI KUSNEZOFFII RADIX COCTA |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 | ||
| LIQUIDAMBARIS RESINA |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 | ||
| Frankincense (processing) |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 | ||
| Myrrh |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 | ||
| Ophiopogon japonicus (fried with vinegar) |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 | ||
| Angelica (fried with wine) |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 | ||
| lumbricus |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 | ||
| Fragrance Ink |
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor
More
Anti-inflammatory, analgesic, blood circulation and blood stasis, anti-tumor |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Isatidis Radix |
|
0 | ||
| Calcium sulfate dihydrate |
|
10101-41-4 | 0 | |
| PHRAGMITIS RHIZOMA |
|
0 | ||
| REHMANNIAE RADIX PRAEPARATA |
|
0 | ||
| CURCUMAE RADIX |
|
0 | ||
| ANEMARRHENAE RHIZOMA |
|
0 | ||
| ACORI TATARINOWII RHIZOMA |
|
0 | ||
| POGOSTEMONIS HERBA |
|
0 | ||
| Forsythiae Fructus |
|
0 | ||
| Starch |
|
9005-25-8 | 78 | |
| β-Cyclodextrin |
|
7585-39-9 | 22 | |
| Lactose |
|
63-42-3 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ranitidine Hydrochloride |
It competitively blocks the binding of histamine to H2 receptors and inhibits gastric acid secretion. It is a potent H2 receptor blocker, and its gastric acid inhibition effect is 5 to 12 times that of cimetidine on a molar basis.
More
It competitively blocks the binding of histamine to H2 receptors and inhibits gastric acid secretion. It is a potent H2 receptor blocker, and its gastric acid inhibition effect is 5 to 12 times that of cimetidine on a molar basis. |
66357-59-3 | 48 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Erythromycin ethylsuccinate |
This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.
More
This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. |
1264-62-6 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Erythromycin ethylsuccinate |
This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia, Chlamydia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.
More
This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia, Chlamydia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. |
1264-62-6 | 25 |